1. Sayyari A.A., Imanzadeh F, Bagheri Yazd S.A, Karami H and Yaghoobi M. Prevalence of intestinal parasitic infections in the Islamic Republic of Iran Eastern Mediterranean Health J 2005; 11: 377-383.

2. Babike MA, Ali MSM and Ahmed ES. Frequency of intestinal parasites among food-handlers in Khartoum. Sudan La Revue de Santé de la Méditerranée orientale 2009; 15: 1098-1104.

3. Panamerican Healh Organization. 2009. Epidemiological Profiles of Neglected Diseases and Other Infections Related to Poverty in Latin America and the Caribbean.Disponible en: http://www.paho.org/hq/dmdocuments/2009/nds-epi-profiles.pdf?ua=1.

4. Chacin-Bonilla L. Las enfermedades parasitarias intestinales como un problema de salud global. Invest Clin 2013; 54: 1-4.

5. Chapín-Bonilla L. El problema de las parasitosis intestinales en Venezuela. Invest Clin 1990; 31: 1-2.

6. Guzmán de Rondón C, Vethencour MA, Galindo M, Chacón N, Wagner C, Nessi A. Comportamiento biológico de Blastocystis hominis en pacientes tratados con Secnidazol (Unidazol®). Soc Venez Microb 2008; 28:66-71.

7. Chacón N, Salinas R, Kuo E, Marquez W, Contreras R. Ocurrencia de Isospora belli, Cryptosporidium spp y Cyclospora cayetanensis en pacientes urbanos evaluados por síntomas gastrointestinales y eosinofilia. Bol. Venez. Infect. 2007; 18(2): 66.

8. Chacón N, Salinas R, Kuo E, Durán Ce, Márquez W, Contreras R. Ocurrencia de Isospora belli, Cryptosporidium spp y Cyclospora cayetanensis en pacientes urbanos evaluados por síntomas gastrointestinales con o sin inmunosupresión. Rev Fac Med 2009, 32: 124-131.

9. Hailu, T. and B. Abera, Performance evaluation of direct saline stool microscopy, Formol ether concentration and Kato Katz diagnostic methods for intestinal parasitosis in the absence of gold standard methods. Trop Doct, 2015. 45(3): p. 178-82.

10. Endris, M., et al., Comparison of the Kato-Katz, Wet Mount, and Formol-Ether Concentration Diagnostic Techniques for Intestinal Helminth Infections in Ethiopia. ISRN Parasitology, 2013. 2013: p. 5.

11. WHO, Basic laboratory methods in medical parasitology. 1991, World Health Organization: Geneva. p. 10–31.

12. Koneman EW y Koneman SA. Diagnostico Microbiológico/Microbiological diagnosis. Editorial Panamericana. 2008. 1961 pp.

13. Trabelsi S¹,Aouinet A,Khaled S. Procedure and indications of stool examination in parasitology. Tunis Med.2012;90:431-434.

14. Chacón N, Contreras R, Márquez W, Salinas R, Romero J. Importancia de la Referencia Médica en el diagnostico de parasitosis intestinales por métodos coproparasitológicos en la Sección de Geohelmintiasis. Instituto de Medicina Tropical -Universidad Central de Venezuela. Rev. Fac. Med. 2007; 30: 90-96.

15. Hernández-Chavarría F. y Avendaño L. A simple Modification of the Baermann Method for Diagnosis of Strongyloidiasis. Mem Inst Oswaldo Cruz 2001; 96(6): 805- 807.

16. Garcia, L.S., Diagnostic medical parasitology. 5th ed. 2007, Washington D.C: ASM Press.

17. Jeandron, A., et al., Accuracy of the Kato-Katz, adhesive tape and FLOTAC techniques for helminth diagnosis among children in Kyrgyzstan. Acta Trop, 2010. 116(3): p. 185-92.

18. KatzN,Chaves A,Pellegrino J. A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo.1972;14(6):397-400.

19. Rossit AR, Gongalves AC, Franco A, Machado RI. Etiological agents of diarrhea in patients infected by the human immunodeficiency virus-1: a review. Rev Inst Med Trop Sao Paulo 2009; 51: 59-65.

20. Gassama A, Sow Ps, Fall f, Camara P, Gueye-N´diaye A, Seng R, Samb B, M`Boup S, Aidara-Kane A. Ordinary and opportunistic enteropathogens associated with diarrhea in Senegalese adults in relation to human immunodeficiency virus serostatus. Int Infect Dis 2001; 5: 192-198.

21. CertadG,Arenas-Pinto A,Pocaterra L,Ferrara G,Castro J,Bello A,Núñez L. Isosporiasis in Venezuelan adults infected with human immunodeficiency virus: clinical characterization. Am J Trop Med Hyg.2003;69(2):217-22.

22. Sanad MM, Al-Malki JS. Cryptosporidiosis among immunocompromised patients in Saudi Arabia. J Infect Dis. 2007;196:684-691.

23. Cama VA, Ross JM, Crawford S, Kawai V, Chavez-Valdez R, Vargas D, et al. Differences in clinical manifestations among Cryptosporidium species and subtypes in HIV-infected persons. Am J Trop Med Hyg. 2005;73:54-57.

24. Certad G, Arenas-Pinto A, Pocaterra L, Ferrara G, Castro J, Bello A, et al. Cryptosporidiosis in HIV-infected Venezuelan adults is strongly associated with acute or chronic diarrhea. Acta Gastroenterol Latinoam. 2004;34:133-137.

25. Velásquez JN, Carnevale S, Cabrera M, Kuo L, Chertcoff A, Mariano M, et al. Cyclospora cayetanensis in patients with AIDS and chronic diarrhea. Acta Gastroenterol Latinoam. 2004;34:133-137.

26. Speich B,Croll D,Fürst T,Utzinger J,Keiser J. Effect of sanitation and water treatment on intestinal protozoa infection: a systematic review and meta-analysis. Lancet Infect Dis.2016:87-99.

27. Takarinda KC,Harries AD,Mutasa-Apollo T. Public Health Action.Critical considerations for adopting the HIV 'treat all' approach in Zimbabwe: is the nation poised? 2016 21;6(1):3-7.

28. Vissi E y Angulo LA. Agentes patógenos responsables de trastornos gastrointestinales en sujetos infectados con VIH. Invest Clin 2013; 54:90-108.

29. Al FD,Hökelek M. IsBlastocystishominis an opportunist agent?. Turkiye Parazitol Derg.2007; 31(1):28-36.

30. Vazquez Guillamet LJ,Saul Z,Miljkovich G,Vilchez GA,Mendonca N,Gourineni V,Lillo N,Pinto M,Baig A,Gangcuangco LM. Strongyloides stercoralis Infection Among Human Immunodeficiency Virus (HIV)-Infected Patients in the United States of America: A Case Report and Review of Literature. Am J Case Rep.2017;18:339-346.

31. World Health Organization. Global report for research on infectious disease of poverty. Ginebra, Suiza: UNICEF/UNDP/World bank/WHO.; 2012, p 11-21.

32. Sewankambo NK, Gray RH, Ahmad S, Serwadda D, Wabwire-Mangen F, Nalugoda F, Kiwanuka N, Lutalo T, Kigozi G, Li C, Meehan MP, Brahmbatt H, Wawer M J. Mortality associated with HIV infection in rural Rakai District, Uganda. AIDS.2000; 14: 2391-2400.

33. Anuario de Mortalidad. Republica Bolivariana de Venezuela. Ministerio del Poder Popular para la Salud. 2012. pp 435.

34. Suárez M. Las ONG unidas en la lucha contra el VIH/Sida El Impulso. 2013. Disponible en: http://elimpulso.com/articulo/las-ong-unidas-en-la-lucha-contra-el-vihsid.

35. Nissapatorn V,Sawangjaroen N Parasiticinfections in HIV infected individuals: diagnostic & therapeutic challenges. Indian J Med Res.2011;134:878-97.

36. Abaza SM, Makhlouf LM,el-Shewy KA,el-Moamly AA. Intestinalopportunisticparasitesamong different groups of immunocompromised hosts. J Egypt Soc Parasitol.1995;25(3):713-727.

37. Uehlinger FD, Greenwood SJ, McClure JT, Conboy G, O'Handley R, Barkema HW. Zoonotic potential of Giardia duodenalis and Cryptosporidium spp. and prevalence of intestinal parasites in young dogs from different populations on Prince Edward Island, Canada.Vet Parasitol. 2013;196(3-4):509-514.

38. Lappin MR. Update on the diagnosis and management ofIsosporaspp infections in dogs and cats. Top Companion Anim Med. 2010;25(3):133-135.

39. Lainson R. The genusCyclospora(Apicomplexa: Eimeriidae), with a description ofCyclosporaschneideri n.sp. in the snake Anilius scytale scytale (Aniliidae) from Amazonian Brazil--a review. Mem Inst Oswaldo Cruz.2005;100(2):103-110.

40. Abanyie F,Harvey RR,Harris JR,Wiegand RE,Gaul L,Desvignes-Kendrick M,et al.Multistate Cyclosporiasis Outbreak Investigation Team. 2013 multistate outbreaks ofCyclosporacayetanensis infections associated with fresh produce: focus on the Texas investigations. Epidemiol Infect.2015 Dec;143(16):3451-3458.

41. Osman M, Bories J, El Safadi D, Poirel MT, Gantois N, Benamrouz-Vanneste S et al. Prevalence and genetic diversity of the intestinal parasites Blastocystis sp. and Cryptosporidium spp. in household dogs in France and evaluation of zoonotic transmission risk. Vet Parasitol. 2015; 214:167-170.

42. Osman M,El Safadi D,Cian A,Benamrouz S,Nourrisson C, Poirier P, et al. MolecularEpidemiologyofBlastocystissp. in Various Animal Groups from Two French Zoos and Evaluation of Potential Zoonotic Risk. PLoSOne.2017;2(1):e0169659.

43. Mirza H,Tan KS. Blastocystisexhibits inter- and intra-subtype variation in cysteineproteaseactivity. Parasitol Res 2009; 104:355-361.

44. Chandramathi S,Suresh K,Sivanandam S,Kuppusamy UR. Stressexacerbates infectivity and pathogenicity ofBlastocystis hominis: in vitro and in vivo evidences. 2014; 9(5):e94567.

45. Batista L,Pérez Jove J,Rosinach M,Gonzalo V,Sainz E,Loras C,Forné M,Esteve M,Fernández-Bañares F. Low efficacy of metronidazole in the eradication ofBlastocystishominis in symptomatic patients: Case series and systematic literature review. Gastroenterol Hepatol.2017Mar 6. pii: S0210-5705(16)30182-0.

46. Wu Z, Mirza H, Tan KS. Intra-subtype variation in enteroadhesion accounts for differences in epithelial barrier disruption and is associated with metronidazole resistance in Blastocystis subtype-7. PLoS Negl Trop Dis. 2014; 22: 8(5):e2885.

47. Nagel R,Bielefeldt-Ohmann H,Traub R. Clinical pilot study: efficacy of triple antibiotic therapy inBlastocystispositive irritable bowel syndrome patients. Gut Pathog. 2014; 20:6-34.

48. Silva-Díaz H,Flores-Esqueche L,Llatas-Cancino D²Guevara Vásquez G,Silva-García T Frequency and in vitro susceptibility antiparasitic ofBlastocystis hominis from patients admitted to the Hospital Regional Lambayeque, Peru. Rev Gastroenterol Peru.2016; 36(3):197-202.

49. Wettstein AR, Borody TJ, Wee T, Torres M. Novel Intra-colonic Infusion of Three Antiparasite Agents for Resistant Blastocystis hominis Infections. Disponible en: http://www.e-learning.ueg.eu/documents-view.html?eprs%5Br%5D=9083 19/12/2012.

50. M. Lepczyńska & J. Białkowska & E. Dzika1 & K. Piskorz-Ogórek & J. Korycińska. Blastocystis: how do specific diets and human gut microbiota affect its development and pathogenicity? Eur J Clin Microbiol Infect Dis. 2017 Mar 22. doi: 10.1007/s10096-017-2965-0. [Epub ahead of print].